Showing results (1-10 of 200) with videos related to
Sort By:
Pageof 20
Journal of General Internal Medicine|September 1, 1994
The effect of changing disease risk on clinical reasoningG H Lyman, L BalducciClinics in Geriatric Medicine|February 1, 1997
Cancer in the elderly. Epidemiologic and clinical implicationsL Balducci, G H LymanJournal of Cancer Education : the Official Journal of the American Association for Cancer Education|January 1, 1993
Overestimation of test effects in clinical judgmentG H Lyman, L BalducciCurrent Opinion in Hematology|May 5, 1999
Update of the economic analyses of the use of the colony-stimulating factorsG H Lyman, L BalducciOncology (Williston Park, N.Y.)|November 1, 1995
A cost analysis of hematopoietic colony-stimulating factorsG H Lyman, L BalducciJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 14, 2000
What threshold for adjuvant therapy in older breast cancer patients?M Extermann, L Balducci, G H LymanCurrent Opinion in Hematology|April 17, 2001
Hematopoietic growth factors in the older cancer patientL Balducci, C L Hardy, G H LymanCancer Control : Journal of the Moffitt Cancer Center|November 23, 2000
Hemopoietic reserve in the older cancer patient: clinical and economic considerationsL Balducci, C L Hardy, G H LymanCurrent Opinion in Oncology|August 14, 1998
Economic impact of granulopoiesis stimulating agents on the management of febrile neutropeniaG H Lyman, N M Kuderer, L BalducciEuropean Journal of Cancer (Oxford, England : 1990)|February 19, 1999
The economics of febrile neutropenia: implications for the use of colony-stimulating factorsG H Lyman, N Kuderer, J Greene, et al.Pageof 20